Shine-On BioMedical Co.,Ltd.
Taipei Exchange 6926.TWO
Shine-On BioMedical Co.,Ltd. Net Income for the year ending December 31, 2023: USD -1.21 M
Shine-On BioMedical Co.,Ltd. Net Income is USD -1.21 M for the year ending December 31, 2023, a -89.89% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
Shine-On BioMedical Co.,Ltd. Net Income for the year ending December 31, 2022 was USD -637.54 K, a -109.62% change year over year.
-
Shine-On BioMedical Co.,Ltd. Net Income for the year ending December 31, 2021 was USD -304.14 K.
Key data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Net Income Margin |
|---|
Market news
Loading...
Taipei Exchange: 6926.TWO
| CEO | Mr. Hongzhe Jiang |
| IPO Date | Nov. 25, 2022 |
| Location | |
| Headquarters | No. 633, Taiwan Avenue |
| Employees | 19 |
| Sector | Health Care |
| Industries | |
Description
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email